200 related articles for article (PubMed ID: 9000703)
1. Reduced insulin, GLUT2, and IDX-1 in beta-cells after partial pancreatectomy.
Zangen DH; Bonner-Weir S; Lee CH; Latimer JB; Miller CP; Habener JF; Weir GC
Diabetes; 1997 Feb; 46(2):258-64. PubMed ID: 9000703
[TBL] [Abstract][Full Text] [Related]
2. Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels.
Gremlich S; Bonny C; Waeber G; Thorens B
J Biol Chem; 1997 Nov; 272(48):30261-9. PubMed ID: 9374511
[TBL] [Abstract][Full Text] [Related]
3. The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration.
Sharma A; Zangen DH; Reitz P; Taneja M; Lissauer ME; Miller CP; Weir GC; Habener JF; Bonner-Weir S
Diabetes; 1999 Mar; 48(3):507-13. PubMed ID: 10078550
[TBL] [Abstract][Full Text] [Related]
4. Loss of glucose-induced insulin secretion and GLUT2 expression in transplanted beta-cells.
Ogawa Y; Noma Y; Davalli AM; Wu YJ; Thorens B; Bonner-Weir S; Weir GC
Diabetes; 1995 Jan; 44(1):75-9. PubMed ID: 7813817
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor.
Waeber G; Thompson N; Nicod P; Bonny C
Mol Endocrinol; 1996 Nov; 10(11):1327-34. PubMed ID: 8923459
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of the insulin gene transcriptional repressor CCAAT/enhancer-binding protein beta and transactivator islet duodenum homeobox-1 in rat pancreatic beta cells during the development of diabetes mellitus.
Seufert J; Weir GC; Habener JF
J Clin Invest; 1998 Jun; 101(11):2528-39. PubMed ID: 9616224
[TBL] [Abstract][Full Text] [Related]
7. Translocation of glucokinase in pancreatic beta-cells during acute and chronic hyperglycemia.
Noma Y; Bonner-Weir S; Latimer JB; Davalli AM; Weir GC
Endocrinology; 1996 Apr; 137(4):1485-91. PubMed ID: 8625927
[TBL] [Abstract][Full Text] [Related]
8. The loss of GLUT2 expression in the pancreatic beta-cells of diabetic db/db mice is associated with an impaired DNA-binding activity of islet-specific trans-acting factors.
Bonny C; Roduit R; Gremlich S; Nicod P; Thorens B; Waeber G
Mol Cell Endocrinol; 1997 Nov; 135(1):59-65. PubMed ID: 9453241
[TBL] [Abstract][Full Text] [Related]
9. Genetic regulation of metabolic pathways in beta-cells disrupted by hyperglycemia.
Laybutt DR; Sharma A; Sgroi DC; Gaudet J; Bonner-Weir S; Weir GC
J Biol Chem; 2002 Mar; 277(13):10912-21. PubMed ID: 11782487
[TBL] [Abstract][Full Text] [Related]
10. Alterations in net glucose uptake and in the pancreatic B-cell GLUT2 transporter induced by diazoxide and by secretory stimuli.
Zhao L; Li Z; Kullin M; Borg LA; Karlsson FA
J Endocrinol; 2005 May; 185(2):291-9. PubMed ID: 15845921
[TBL] [Abstract][Full Text] [Related]
11. beta-cell adaptation in 60% pancreatectomy rats that preserves normoinsulinemia and normoglycemia.
Liu YQ; Nevin PW; Leahy JL
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E68-73. PubMed ID: 10893324
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagonlike peptide-1 (7-37).
Hosokawa YA; Hosokawa H; Chen C; Leahy JL
J Clin Invest; 1996 Jan; 97(1):180-6. PubMed ID: 8550831
[TBL] [Abstract][Full Text] [Related]
13. Long-term exposure of isolated rat islets of Langerhans to supraphysiologic glucose concentrations decreases insulin mRNA levels.
Briaud I; Rouault C; Reach G; Poitout V
Metabolism; 1999 Mar; 48(3):319-23. PubMed ID: 10094107
[TBL] [Abstract][Full Text] [Related]
14. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
[TBL] [Abstract][Full Text] [Related]
15. Critical reduction in beta-cell mass results in two distinct outcomes over time. Adaptation with impaired glucose tolerance or decompensated diabetes.
Laybutt DR; Glandt M; Xu G; Ahn YB; Trivedi N; Bonner-Weir S; Weir GC
J Biol Chem; 2003 Jan; 278(5):2997-3005. PubMed ID: 12438314
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic islet GLUT2 glucose transporter mRNA and protein expression in humans with and without NIDDM.
Ferrer J; Benito C; Gomis R
Diabetes; 1995 Dec; 44(12):1369-74. PubMed ID: 7589840
[TBL] [Abstract][Full Text] [Related]
17. Altered beta-cell distribution of pdx-1 and GLUT-2 after a short-term challenge with a high-fat diet in C57BL/6J mice.
Reimer MK; Ahrén B
Diabetes; 2002 Feb; 51 Suppl 1():S138-43. PubMed ID: 11815473
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of oleic acid deterioration in insulin secretion: role in the pathogenesis of type 2 diabetes.
Zhang Y; Xiao M; Niu G; Tan H
Life Sci; 2005 Sep; 77(17):2071-81. PubMed ID: 15935394
[TBL] [Abstract][Full Text] [Related]
19. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
Jetton TL; Liang Y; Cincotta AH
Metabolism; 2001 Nov; 50(11):1377-84. PubMed ID: 11699060
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-gamma regulates expression of PDX-1 and NKX6.1 in INS-1 cells.
Moibi JA; Gupta D; Jetton TL; Peshavaria M; Desai R; Leahy JL
Diabetes; 2007 Jan; 56(1):88-95. PubMed ID: 17192469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
